Skip to main content
logo
Abera Bioscience AB (NGM:ABERA)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.56
-0.04 (-0.61%)
At close: May 25, 2026

Abera Bioscience AB Revenue

Abera Bioscience AB had revenue of 3.55M SEK in the quarter ending March 31, 2026, a decrease of -0.59%. This brings the company's revenue in the last twelve months to 11.87M, down -25.53% year-over-year. In the year 2025, Abera Bioscience AB had annual revenue of 11.89M, down -18.74%.

Revenue (ttm)
11.87M
Revenue Growth
-25.53%
P/S Ratio
11.33
Revenue / Employee
2.37M
Employees
5
Market Cap
134.47M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.89M-2.74M-18.74%
Dec 31, 202414.63M12.11M479.60%
Dec 31, 20232.52M736.19K41.18%
Dec 31, 20221.79M609.91K51.78%
Dec 31, 20211.18M422.43K55.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seamless Distribution Systems AB157.61M
Solution International Nordics AB116.58M
Fable Media Group AB61.59M
Aquaticus Real Estate AB52.90M
EmbeddedArt Group AB50.41M
Prolight Diagnostics AB42.20M
Nowonomics AB19.60M
Suntrade Group AB6.16M
Revenue Rankings

Abera Bioscience AB News

More News